Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P: Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol. 2007, 18 (3): 581-592. 10.1093/annonc/mdl498.
Article
CAS
PubMed
Google Scholar
Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, et al: Molecular portraits of human breast tumours. Nature. 2000, 406 (6797): 747-752. 10.1038/35021093.
Article
CAS
PubMed
Google Scholar
Hanahan D, Weinberg RA: The hallmarks of cancer. Cell. 2000, 100 (1): 57-70. 10.1016/S0092-8674(00)81683-9.
Article
CAS
PubMed
Google Scholar
Huang W, Ma K, Zhang J, Qatanani M, Cuvillier J, Liu J, Dong B, Huang X, Moore DD: Nuclear receptor-dependent bile acid signaling is required for normal liver regeneration. Science. 2006, 312 (5771): 233-236. 10.1126/science.1121435.
Article
CAS
PubMed
Google Scholar
Thorne J, Campbell MJ: The vitamin D receptor in cancer. Proc Nutr Soc. 2008, 67 (2): 115-127. 10.1017/S0029665108006964.
Article
CAS
PubMed
Google Scholar
Deeb KK, Trump DL, Johnson CS: Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer. 2007, 7 (9): 684-700. 10.1038/nrc2196.
Article
CAS
PubMed
Google Scholar
Dusso AS, Brown AJ, Slatopolsky E: Vitamin D. Am J Physiol Renal Physiol. 2005, 289 (1): F8-28. 10.1152/ajprenal.00336.2004.
Article
CAS
PubMed
Google Scholar
Mantell DJ, Owens PE, Bundred NJ, Mawer EB, Canfield AE: 1 alpha,25-dihydroxyvitamin D(3) inhibits angiogenesis in vitro and in vivo. Circ Res. 2000, 87 (3): 214-220.
Article
CAS
PubMed
Google Scholar
Hansen CM, Frandsen TL, Brunner N, Binderup L: 1 alpha,25-Dihydroxyvitamin D3 inhibits the invasive potential of human breast cancer cells in vitro. Clin Exp Metastasis. 1994, 12 (3): 195-202. 10.1007/BF01753887.
Article
CAS
PubMed
Google Scholar
Eisman JA, Martin TJ, MacIntyre I, Moseley JM: 1,25-dihydroxyvitamin-D-receptor in breast cancer cells. Lancet. 1979, 2 (8156-8157): 1335-1336. 10.1016/S0140-6736(79)92816-2.
Article
CAS
PubMed
Google Scholar
Evans RM: The steroid and thyroid hormone receptor superfamily. Science. 1988, 240 (4854): 889-895. 10.1126/science.3283939.
Article
CAS
PubMed
Google Scholar
Zinser GM, McEleney K, Welsh J: Characterization of mammary tumor cell lines from wild type and vitamin D3 receptor knockout mice. Mol Cell Endocrinol. 2003, 200 (1-2): 67-80. 10.1016/S0303-7207(02)00416-1.
Article
CAS
PubMed
Google Scholar
Zinser GM, Suckow M, Welsh J: Vitamin D receptor (VDR) ablation alters carcinogen-induced tumorigenesis in mammary gland, epidermis and lymphoid tissues. J Steroid Biochem Mol Biol. 2005, 97 (1-2): 153-164. 10.1016/j.jsbmb.2005.06.024.
Article
CAS
PubMed
Google Scholar
Berger U, Wilson P, McClelland RA, Colston K, Haussler MR, Pike JW, Coombes RC: Immunocytochemical detection of 1,25-dihydroxyvitamin D receptors in normal human tissues. J Clin Endocrinol Metab. 1988, 67 (3): 607-613. 10.1210/jcem-67-3-607.
Article
CAS
PubMed
Google Scholar
Freake HC, Abeyasekera G, Iwasaki J, Marcocci C, MacIntyre I, McClelland RA, Skilton RA, Easton DF, Coombes RC: Measurement of 1,25-dihydroxyvitamin D3 receptors in breast cancer and their relationship to biochemical and clinical indices. Cancer Res. 1984, 44 (4): 1677-1681.
CAS
PubMed
Google Scholar
Haussler MR, Whitfield GK, Haussler CA, Hsieh JC, Thompson PD, Selznick SH, Dominguez CE, Jurutka PW: The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res. 1998, 13 (3): 325-349. 10.1359/jbmr.1998.13.3.325.
Article
CAS
PubMed
Google Scholar
Townsend K, Banwell CM, Guy M, Colston KW, Mansi JL, Stewart PM, Campbell MJ, Hewison M: Autocrine metabolism of vitamin D in normal and malignant breast tissue. Clin Cancer Res. 2005, 11 (9): 3579-3586. 10.1158/1078-0432.CCR-04-2359.
Article
CAS
PubMed
Google Scholar
McCarthy K, Laban C, Bustin SA, Ogunkolade W, Khalaf S, Carpenter R, Jenkins PJ: Expression of 25-hydroxyvitamin D-1-alpha-hydroxylase, and vitamin D receptor mRNA in normal and malignant breast tissue. Anticancer Res. 2009, 29 (1): 155-157.
PubMed
Google Scholar
Matos I, Dufloth R, Alvarenga M, Zeferino LC, Schmitt F: p63, cytokeratin 5, and P-cadherin: three molecular markers to distinguish basal phenotype in breast carcinomas. Virchows Arch. 2005, 447 (4): 688-694. 10.1007/s00428-005-0010-7.
Article
CAS
PubMed
Google Scholar
Bacus S, Flowers JL, Press MF, Bacus JW, McCarty KS: The evaluation of estrogen receptor in primary breast carcinoma by computer-assisted image analysis. Am J Clin Pathol. 1988, 90 (3): 233-239.
Article
CAS
PubMed
Google Scholar
Paredes J, Lopes N, Milanezi F, Schmitt FC: P-cadherin and cytokeratin 5: useful adjunct markers to distinguish basal-like ductal carcinomas in situ. Virchows Arch. 2007, 450 (1): 73-80. 10.1007/s00428-006-0334-y.
Article
CAS
PubMed
Google Scholar
Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001, 25 (4): 402-408. 10.1006/meth.2001.1262.
Article
CAS
PubMed
Google Scholar
Nielsen TO, Hsu FD, Jensen K, Cheang M, Karaca G, Hu Z, Hernandez-Boussard T, Livasy C, Cowan D, Dressler L, et al: Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res. 2004, 10 (16): 5367-5374. 10.1158/1078-0432.CCR-04-0220.
Article
CAS
PubMed
Google Scholar
Friedrich M, Axt-Fliedner R, Villena-Heinsen C, Tilgen W, Schmidt W, Reichrath J: Analysis of vitamin D-receptor (VDR) and retinoid X-receptor alpha in breast cancer. Histochem J. 2002, 34 (1-2): 35-40. 10.1023/A:1021343825552.
Article
CAS
PubMed
Google Scholar
Segersten U, Holm PK, Bjorklund P, Hessman O, Nordgren H, Binderup L, Akerstrom G, Hellman P, Westin G: 25-Hydroxyvitamin D3 1alpha-hydroxylase expression in breast cancer and use of non-1alpha-hydroxylated vitamin D analogue. Breast Cancer Res. 2005, 7 (6): R980-986. 10.1186/bcr1332.
Article
CAS
PubMed
PubMed Central
Google Scholar
Berger U, Wilson P, McClelland RA, Colston K, Haussler MR, Pike JW, Coombes RC: Immunocytochemical detection of 1,25-dihydroxyvitamin D3 receptor in breast cancer. Cancer Res. 1987, 47 (24 Pt 1): 6793-6799.
CAS
PubMed
Google Scholar
Berger U, McClelland RA, Wilson P, Greene GL, Haussler MR, Pike JW, Colston K, Easton D, Coombes RC: Immunocytochemical determination of estrogen receptor, progesterone receptor, and 1,25-dihydroxyvitamin D3 receptor in breast cancer and relationship to prognosis. Cancer Res. 1991, 51 (1): 239-244.
CAS
PubMed
Google Scholar
Friedrich M, Rafi L, Tilgen W, Schmidt W, Reichrath J: Expression of 1,25-dihydroxy vitamin D3 receptor in breast carcinoma. J Histochem Cytochem. 1998, 46 (11): 1335-1337.
Article
CAS
PubMed
Google Scholar
Swami S, Krishnan AV, Feldman D: 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells. Clin Cancer Res. 2000, 6 (8): 3371-3379.
CAS
PubMed
Google Scholar
Stoica A, Saceda M, Fakhro A, Solomon HB, Fenster BD, Martin MB: Regulation of estrogen receptor-alpha gene expression by 1, 25-dihydroxyvitamin D in MCF-7 cells. J Cell Biochem. 1999, 75 (4): 640-651. 10.1002/(SICI)1097-4644(19991215)75:4<640::AID-JCB10>3.0.CO;2-8.
Article
CAS
PubMed
Google Scholar
Matusiak D, Murillo G, Carroll RE, Mehta RG, Benya RV: Expression of vitamin D receptor and 25-hydroxyvitamin D3-1{alpha}-hydroxylase in normal and malignant human colon. Cancer Epidemiol Biomarkers Prev. 2005, 14 (10): 2370-2376. 10.1158/1055-9965.EPI-05-0257.
Article
CAS
PubMed
Google Scholar
Matusiak D, Benya RV: CYP27A1 and CYP24 expression as a function of malignant transformation in the colon. J Histochem Cytochem. 2007, 55 (12): 1257-1264. 10.1369/jhc.7A7286.2007.
Article
CAS
PubMed
Google Scholar
Albertson DG, Ylstra B, Segraves R, Collins C, Dairkee SH, Kowbel D, Kuo WL, Gray JW, Pinkel D: Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Nat Genet. 2000, 25 (2): 144-146. 10.1038/75985.
Article
CAS
PubMed
Google Scholar
de Lyra EC, da Silva IA, Katayama ML, Brentani MM, Nonogaki S, Goes JC, Folgueira MA: 25(OH)D3 and 1,25(OH)2D3 serum concentration and breast tissue expression of 1alpha-hydroxylase, 24-hydroxylase and Vitamin D receptor in women with and without breast cancer. J Steroid Biochem Mol Biol. 2006, 100 (4-5): 184-192. 10.1016/j.jsbmb.2006.04.009.
Article
PubMed
Google Scholar
Mohri T, Nakajima M, Takagi S, Komagata S, Yokoi T: MicroRNA regulates human vitamin D receptor. Int J Cancer. 2009, 125 (6): 1328-1333. 10.1002/ijc.24459.
Article
CAS
PubMed
Google Scholar
Komagata S, Nakajima M, Takagi S, Mohri T, Taniya T, Yokoi T: Human CYP24 catalyzing the inactivation of calcitriol is post-transcriptionally regulated by miR-125b. Mol Pharmacol. 2009, 76 (4): 702-709. 10.1124/mol.109.056986.
Article
CAS
PubMed
Google Scholar
Kemmis CM, Welsh J: Mammary epithelial cell transformation is associated with deregulation of the vitamin D pathway. J Cell Biochem. 2008, 105 (4): 980-988. 10.1002/jcb.21896.
Article
CAS
PubMed
PubMed Central
Google Scholar
Welsh J: Vitamin D and breast cancer: insights from animal models. Am J Clin Nutr. 2004, 80 (6 Suppl): 1721S-1724S.
CAS
PubMed
Google Scholar